DJIA 17,683.58 -46.53 -0.26%
NASDAQ 4,991.94 -17.27 -0.34%
S&P 500 2,068.76 -8.02 -0.39%
market minute promo

Johnson & Johnson (NYSE: JNJ)

98.20 -0.24 (-0.24%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

JNJ $98.20 -0.24%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $97.71
Previous Close $98.44
Daily Range $96.64 - $98.50
52-Week Range $95.10 - $109.49
Market Cap $272.3B
P/E Ratio 17.61
Dividend (Yield) $3.00 (3.0%)
Ex-Dividend Date
Dividend Pay Date
Volume 6,817,541
Average Daily Volume 7,626,978
Current FY EPS $6.14




Drug Makers

Johnson & Johnson (JNJ) Description

A vast and diverse health care giant, Johnson & Johnson strives to help people get well through its consumer products, pharmaceuticals, and medical devices. Website:

News & Commentary

This Could Be Johnson & Johnson’s Future

As competition heats up for Johnson & Johnson's current blockbuster drugs like Zytiga and Remicade, we have to look into the pipeline to see what the future could hold.

U.S. Women's Soccer Team Looks to Score Off the Field, Too

4 Stocks Winning from U.S. Soccer Sponsorships

Retirement Strategy: The Withdrawal Phase Might Not Be As Frightening As You Think

Can You Retire Worry-Free On Less Than $1 Million?

Hidden in Plain Sight: 5 Best Stocks in Pharmaceuticals

Great opportunities to consider for the rest of 2015 and beyond.

Scanning The SA Family For Alpha: Rosenose

5 Figures to Monitor Ahead of Johnson & Johnson's Second-Quarter Report

Johnson & Johnson's second-quarter earnings release is less than two weeks away. Here are five figures you need to be on top of when its results are released.

Gilead Submits Marketing Application for HIV Drug to FDA - Analyst Blog

Portfolio Rehab - 2nd Quarter Update

See More JNJ News...

JNJ's Top Competitors

JNJ $98.20 (-0.24%)
Current stock: JNJ
ABT $49.74 (0.67%)
Current stock: ABT
BSX $17.55 (-0.11%)
Current stock: BSX
MRK $57.55 (-0.21%)
Current stock: MRK